Tyra Biosciences’ Chief Discovery Officer Sells 8,000 Shares Amid Steady Stock, Sparking Insider Confidence Debate
Tyra Biosciences insider selling: Bensen Daniel’s 8,000‑share Plan 10b‑5‑1 sale shows routine liquidity, not a warning—watch the pipeline for upside.
3 minutes to read